THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ:AMGN) will participate in the UBS Global Life Sciences Conference on Tuesday, Sept. 23, 2008, at the Grand Hyatt in New York City, beginning at 10:30 a.m. Eastern Time. Roger M. Perlmutter, M.D., Ph.D., executive vice president, Research and Development for Amgen, will present at the conference. Live audio of the presentation will be available over the Internet and can be accessed from Amgen’s Web site, www.amgen.com, under Investors.
